Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 12Unspecified Adult Solid Tumor, Protocol Specific 3Breast Neoplasms 3Precancerous Conditions 2Lung Neoplasms 2Hypocalcemia 2Vitamin D Deficiency 1Tuberous Sclerosis 1Tobacco Use Disorder 1Thyroiditis 1Thyroid Nodule 1Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pinealoma 1Pancreatic Neoplasms 1Osteoporosis 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Meningioma 1Melanoma 1Medulloblastoma 1Leukemia 1Hyperthyroidism 1Hyperplasia 1Hyperparathyroidism 1Goiter 1

Interventions

Gemcitabine 406Oxaliplatin 131Fluorouracil 125130-nm albumin-bound paclitaxel 108Capecitabine 100Albumin-Bound Paclitaxel 90Leucovorin 88Irinotecan 87Radiotherapy 76Radiosurgery 64Taxes 63Cisplatin 56Erlotinib Hydrochloride 44Drug Therapy 42folfirinox 40Magnetic Resonance Spectroscopy 39pembrolizumab 35Blood Specimen Collection 33S 1 (combination) 31Pancreaticoduodenectomy 31Docetaxel 31Nivolumab 30Bevacizumab 30Biopsy 26Surgical Procedures, Operative 25Cyclophosphamide 25irinotecan sucrosofate 24Specimen Handling 24Radiation 22Standard of Care 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Neoplasms × Calcitriol × Clear all
NCT00238199 2015-04-24

Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡